ALLANTOIN

ALLANTOIN was reported 3308 times

ALLANTOIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER THERAPY 88 0.4444
1 ANTACID THERAPY 48 0.3692
2 APPENDICOLITH 131 0.3385
3 ANALGESIC THERAPY 89 0.2773
4 DRUG THERAPY 86 0.2537
5 CONGENITAL HIATUS HERNIA 49 0.2149
6 MALIGNANT MELANOMA STAGE 0 40 0.1914
7 ANTICOAGULANT THERAPY 48 0.1690
8 BACTEROIDES INFECTION 30 0.1149
9 HYPERPHOSPHATAEMIA 109 0.0507
10 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 43 0.0464
11 BREATH SOUNDS DECREASED 4 0.0455
12 BLOOD PHOSPHORUS INCREASED 124 0.0454
13 VENTRICLE RUPTURE 4 0.0294
14 ELECTROCARDIOGRAM POOR R-WAVE PROGRESSION 4 0.0272
15 TOTAL LUNG CAPACITY DECREASED 39 0.0244
16 BLOOD URIC ACID INCREASED 102 0.0176
17 IRON DEFICIENCY 78 0.0173
18 HYPOPHOSPHATAEMIA 119 0.0161
19 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 81 0.0160
20 MYASTHENIA GRAVIS 126 0.0156
21 APPENDICITIS 134 0.0143
22 PLEURITIC PAIN 39 0.0141
23 LUNG OPACITY 36 0.0136
24 AORTIC STENOSIS 45 0.0129
25 VENTRICULAR FIBRILLATION 140 0.0126
26 RESPIRATORY SYMPTOM 34 0.0119
27 SOCIAL PHOBIA 4 0.0116
28 GLASGOW COMA SCALE ABNORMAL 4 0.0109
29 CORONARY ARTERY SURGERY 3 0.0097
30 STENT OCCLUSION 5 0.0094
31 CARDIOGENIC SHOCK 129 0.0090
32 DYSPHASIA 4 0.0086
33 FAECAL OCCULT BLOOD POSITIVE 3 0.0085
34 BENIGN PROSTATIC HYPERPLASIA 44 0.0085
35 POSTOPERATIVE INFECTION 4 0.0084
36 TROPONIN INCREASED 63 0.0083
37 RIGHT ATRIAL DILATATION 4 0.0079
38 BRONCHITIS ACUTE 3 0.0075
39 CSF PROTEIN INCREASED 6 0.0072
40 BREATH SOUNDS ABNORMAL 35 0.0071
41 BLOOD CALCIUM INCREASED 62 0.0071
42 THERAPEUTIC AGENT TOXICITY 23 0.0069
43 OPERATIVE HAEMORRHAGE 3 0.0067
44 LOCALISED INTRAABDOMINAL FLUID COLLECTION 3 0.0067
45 BIOPSY BONE MARROW ABNORMAL 3 0.0066
46 BACTERIAL INFECTION 123 0.0066
47 PROGESTERONE RECEPTOR ASSAY POSITIVE 6 0.0064
48 MARKEDLY REDUCED DIETARY INTAKE 3 0.0061
49 CARDIOACTIVE DRUG LEVEL INCREASED 8 0.0061
50 ENCEPHALITIS HERPES 3 0.0061
51 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 101 0.0059
52 HYPERLIPIDAEMIA 69 0.0058
53 CARDIAC ENZYMES INCREASED 4 0.0056
54 POSTNASAL DRIP 3 0.0054
55 OESTROGEN RECEPTOR ASSAY POSITIVE 6 0.0053
56 MULTIPLE ORGAN DYSFUNCTION SYNDROME 149 0.0053
57 SLEEP WALKING 3 0.0052
58 QRS AXIS ABNORMAL 4 0.0052
59 NEURALGIA 126 0.0052
60 INJECTION SITE BURNING 4 0.0051
61 SHOULDER PAIN 5 0.0051
62 GRUNTING 3 0.0050
63 ASCITES 144 0.0049
64 NEPHRITIS INTERSTITIAL 6 0.0047
65 PRESSURE OF SPEECH 3 0.0046
66 ULCER 73 0.0046
67 ASPIRATION 50 0.0046
68 COMPLEX PARTIAL SEIZURES 5 0.0045
69 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 3 0.0044
70 ACUTE PRERENAL FAILURE 5 0.0043
71 GOUT 76 0.0042
72 HEPATIC CONGESTION 4 0.0042
73 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 6 0.0041
74 BLOOD TEST ABNORMAL 58 0.0041
75 CLOSTRIDIUM COLITIS 5 0.0041
76 DYSPNOEA PAROXYSMAL NOCTURNAL 3 0.0041
77 EARLY SATIETY 8 0.0041
78 AORTIC VALVE SCLEROSIS 3 0.0041
79 BENIGN NEOPLASM OF THYROID GLAND 3 0.0041
80 DIFFICULTY IN WALKING 14 0.0041
81 PUPIL FIXED 7 0.0040
82 HYPERCHOLESTEROLAEMIA 39 0.0040
83 NEGATIVISM 3 0.0040
84 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 3 0.0038
85 GOUTY ARTHRITIS 3 0.0038
86 ELECTROMECHANICAL DISSOCIATION 3 0.0038
87 LYMPHOCYTE STIMULATION TEST POSITIVE 3 0.0037
88 END STAGE RENAL DISEASE 68 0.0037
89 COLONIC POLYP 6 0.0036
90 PROTHROMBIN TIME SHORTENED 5 0.0036
91 FULL BLOOD COUNT ABNORMAL 37 0.0035
92 SICK SINUS SYNDROME 4 0.0035
93 SENSATION OF PRESSURE 3 0.0034
94 MICTURITION URGENCY 38 0.0033
95 RALES 19 0.0033
96 LOBAR PNEUMONIA 6 0.0032
97 RETINAL EXUDATES 3 0.0032
98 PHARMACEUTICAL PRODUCT COMPLAINT 82 0.0032
99 COR PULMONALE 3 0.0031
100 LEFT ATRIAL DILATATION 4 0.0031
101 HYPONATRAEMIA 175 0.0031
102 ABNORMAL SLEEP-RELATED EVENT 4 0.0030
103 ANGIONEUROTIC OEDEMA 8 0.0030
104 CATHETER RELATED INFECTION 3 0.0030
105 DRUG TOXICITY 40 0.0029
106 BLOOD AMYLASE INCREASED 5 0.0029
107 BLOOD CHLORIDE INCREASED 5 0.0029
108 CULTURE URINE POSITIVE 4 0.0028
109 HEPATIC NEOPLASM MALIGNANT 6 0.0028
110 DIABETES MELLITUS NON-INSULIN-DEPENDENT 4 0.0027
111 CANDIDIASIS 11 0.0027
112 ANOREXIA 35 0.0027
113 STOMACH DISCOMFORT 14 0.0027
114 HEPATOCELLULAR DAMAGE 6 0.0027
115 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 135 0.0026
116 MULTIPLE INJURIES 16 0.0025
117 INAPPROPRIATE AFFECT 4 0.0025
118 BRONCHIECTASIS 17 0.0025
119 BLOOD CHOLESTEROL INCREASED 115 0.0025
120 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 10 0.0024
121 BLOOD CULTURE POSITIVE 7 0.0023
122 IATROGENIC INJURY 3 0.0023
123 VENTRICULAR DYSFUNCTION 6 0.0023
124 MUSCLE CRAMP 4 0.0023
125 ANAESTHETIC COMPLICATION 6 0.0022
126 ABORTION INCOMPLETE 4 0.0021
127 HAEMODIALYSIS 18 0.0021
128 ANTICONVULSANT DRUG LEVEL DECREASED 3 0.0021
129 CYTOLYTIC HEPATITIS 7 0.0021
130 PULSE ABSENT 10 0.0021
131 VISUAL DISTURBANCE 12 0.0021
132 HYPOAESTHESIA FACIAL 3 0.0020
133 CHEST X-RAY ABNORMAL 6 0.0020
134 CORONARY ARTERY DISEASE 59 0.0019
135 TRANSAMINASES INCREASED 43 0.0019
136 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
137 JOINT INJURY 41 0.0019
138 DIABETES MELLITUS 144 0.0019
139 ORTHOPNOEA 6 0.0019
140 INCORRECT DOSE ADMINISTERED BY PRODUCT 3 0.0019
141 DRY MOUTH 152 0.0019
142 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
143 IRON DEFICIENCY ANAEMIA 17 0.0018
144 PROTHROMBIN TIME PROLONGED 11 0.0018
145 PERICARDIAL HAEMORRHAGE 4 0.0018
146 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
147 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 6 0.0018
148 RETROPERITONEAL HAEMATOMA 4 0.0018
149 BLOOD CREATINE INCREASED 8 0.0018
150 CORONARY ARTERY STENOSIS 9 0.0018
151 HEPATORENAL SYNDROME 3 0.0018
152 SLEEP DISORDER 125 0.0018
153 NEUROPATHY 3 0.0018
154 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0018
155 ECONOMIC PROBLEM 26 0.0017
156 PSEUDOMONAL SEPSIS 3 0.0017
157 MITRAL VALVE DISEASE 3 0.0017
158 CARDIOVASCULAR DISORDER 43 0.0017
159 SPUTUM DISCOLOURED 16 0.0017
160 REFUSAL OF TREATMENT BY PATIENT 11 0.0017
161 AORTIC VALVE STENOSIS 3 0.0017
162 THROMBOSIS 134 0.0017
163 LOSS OF EMPLOYMENT 5 0.0017
164 ORAL INTAKE REDUCED 4 0.0017
165 BUNDLE BRANCH BLOCK LEFT 7 0.0016
166 AORTIC VALVE INCOMPETENCE 7 0.0016
167 SEPSIS 182 0.0016
168 DRUG ABUSER 10 0.0016
169 RETROPERITONEAL HAEMORRHAGE 4 0.0016
170 MULTIPLE DRUG OVERDOSE 8 0.0016
171 VENTRICULAR HYPERTROPHY 4 0.0016
172 BLOOD BICARBONATE DECREASED 3 0.0016
173 ABDOMINAL DISTENSION 165 0.0016
174 RENAL FAILURE CHRONIC 12 0.0016
175 VENTRICULAR HYPOKINESIA 5 0.0016
176 MULTIPLE DRUG OVERDOSE INTENTIONAL 5 0.0016
177 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0015
178 OCCULT BLOOD POSITIVE 3 0.0015
179 PHARYNGOLARYNGEAL PAIN 8 0.0015
180 FOAMING AT MOUTH 3 0.0015
181 KIDNEY TRANSPLANT REJECTION 7 0.0015
182 TRANSIENT ISCHAEMIC ATTACK 49 0.0015
183 GENERAL PHYSICAL HEALTH DETERIORATION 168 0.0015
184 LOWER RESPIRATORY TRACT INFECTION 66 0.0014
185 INSULIN RESISTANCE 3 0.0014
186 PULMONARY EMBOLISM 137 0.0014
187 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
188 CAROTID ARTERY STENOSIS 5 0.0014
189 BLOOD CREATININE INCREASED 93 0.0014
190 MITRAL VALVE INCOMPETENCE 16 0.0014
191 HAEMORRHAGIC DIATHESIS 5 0.0014
192 AMYOTROPHIC LATERAL SCLEROSIS 3 0.0014
193 SWELLING 130 0.0014
194 FACIAL PALSY 3 0.0014
195 DRUG INTOLERANCE 133 0.0014
196 RENAL FAILURE ACUTE 58 0.0014
197 HYPOMANIA 5 0.0014
198 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
199 ALCOHOL USE 5 0.0014
200 IMPULSIVE BEHAVIOUR 5 0.0013
201 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
202 INTENTIONAL PRODUCT MISUSE 116 0.0013
203 SELF INJURIOUS BEHAVIOUR 4 0.0013
204 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
205 RESPIRATORY RATE DECREASED 4 0.0013
206 DIALYSIS 18 0.0013
207 NON-CARDIAC CHEST PAIN 4 0.0013
208 ASPARTATE AMINOTRANSFERASE INCREASED 67 0.0013
209 AZOTAEMIA 5 0.0013
210 MUSCLE HAEMORRHAGE 5 0.0012
211 ENTEROCOCCAL INFECTION 6 0.0012
212 HYPOVENTILATION 4 0.0012
213 THROMBOSIS IN DEVICE 4 0.0012
214 LIVER FUNCTION TEST INCREASED 26 0.0012
215 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
216 PULMONARY MASS 18 0.0012
217 SOCIAL PROBLEM 5 0.0012
218 CONVULSION 69 0.0012
219 STEM CELL TRANSPLANT 3 0.0012
220 GRAND MAL CONVULSION 11 0.0012
221 MENTAL STATUS CHANGES 33 0.0012
222 PLEURAL EFFUSION 72 0.0012
223 LUNG NEOPLASM 5 0.0012
224 MENOPAUSE 3 0.0012
225 BLOOD CHLORIDE DECREASED 3 0.0012
226 ANURIA 10 0.0012
227 BREAST CANCER FEMALE 31 0.0012
228 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
229 PERIORBITAL OEDEMA 6 0.0012
230 PULMONARY FIBROSIS 22 0.0011
231 URINE OUTPUT DECREASED 10 0.0011
232 CARDIOMEGALY 14 0.0011
233 BLOOD UREA INCREASED 19 0.0011
234 LUNG INFILTRATION 10 0.0011
235 WHEELCHAIR USER 5 0.0011
236 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
237 ANGINA UNSTABLE 7 0.0011
238 UPPER RESPIRATORY TRACT INFECTION 49 0.0011
239 OEDEMA PERIPHERAL 129 0.0011
240 HYPOGLYCAEMIC COMA 3 0.0010
241 SOMNOLENCE 209 0.0010
242 ESCHERICHIA SEPSIS 3 0.0010
243 ATELECTASIS 10 0.0010
244 SENSATION OF HEAVINESS 4 0.0010
245 TRICUSPID VALVE INCOMPETENCE 8 0.0010
246 ODYNOPHAGIA 6 0.0010
247 HAEMOPTYSIS 28 0.0010
248 CEREBRAL ATROPHY 4 0.0010
249 OBSTRUCTION 4 0.0010
250 DERMATITIS EXFOLIATIVE 5 0.0010
251 ATRIOVENTRICULAR BLOCK SECOND DEGREE 3 0.0010
252 ANAEMIA 188 0.0010
253 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
254 RECTAL CANCER 3 0.0010
255 FEMORAL NECK FRACTURE 5 0.0010
256 INCREASED UPPER AIRWAY SECRETION 5 0.0010
257 SELF-MEDICATION 4 0.0010
258 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
259 ANOSMIA 14 0.0010
260 HAEMATOCRIT DECREASED 19 0.0010
261 BLOOD GLUCOSE DECREASED 46 0.0010
262 LIVER DISORDER 42 0.0009
263 CAESAREAN SECTION 11 0.0009
264 NYSTAGMUS 5 0.0009
265 ABDOMINAL PAIN 218 0.0009
266 SINUS BRADYCARDIA 9 0.0009
267 INCOHERENT 6 0.0009
268 MULTI-ORGAN FAILURE 16 0.0009
269 LIVER ABSCESS 3 0.0009
270 RENAL TUBULAR NECROSIS 9 0.0009
271 DIVERTICULUM INTESTINAL 4 0.0009
272 DRUG EXPOSURE DURING PREGNANCY 31 0.0009
273 VENTRICULAR TACHYCARDIA 15 0.0009
274 PURPURA 8 0.0009
275 CLOSTRIDIAL INFECTION 3 0.0009
276 POST PROCEDURAL COMPLICATION 17 0.0009
277 PERONEAL NERVE PALSY 5 0.0009
278 HYPERBILIRUBINAEMIA 9 0.0009
279 ARTHRITIS INFECTIVE 4 0.0009
280 EXTRASYSTOLES 6 0.0009
281 MULTIPLE MYELOMA 4 0.0009
282 RIGHT VENTRICULAR FAILURE 6 0.0009
283 MUSCULOSKELETAL STIFFNESS 75 0.0009
284 HYPOXIA 30 0.0009
285 SUDDEN DEATH 9 0.0008
286 CARDIAC TAMPONADE 4 0.0008
287 CONDITION AGGRAVATED 255 0.0008
288 LUNG DISORDER 41 0.0008
289 BLOOD PRESSURE INADEQUATELY CONTROLLED 5 0.0008
290 LIVER TRANSPLANT 3 0.0008
291 CONSTIPATION 179 0.0008
292 NO THERAPEUTIC RESPONSE 10 0.0008
293 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
294 CARDIOMYOPATHY 12 0.0008
295 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
296 ABDOMINAL TENDERNESS 4 0.0008
297 PREGNANCY 16 0.0008
298 PROTEIN TOTAL DECREASED 3 0.0008
299 HEPATIC NECROSIS 3 0.0008
300 LIVER FUNCTION TEST ABNORMAL 23 0.0008
301 DYSLIPIDAEMIA 4 0.0008
302 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
303 OESOPHAGEAL ULCER 3 0.0008
304 DRUG EFFECT DECREASED 42 0.0008
305 CACHEXIA 4 0.0008
306 PERIPHERAL VASCULAR DISORDER 4 0.0008
307 SINUS TACHYCARDIA 11 0.0008
308 ELECTROLYTE IMBALANCE 9 0.0008
309 APNOEA 6 0.0008
310 VENTRICULAR EXTRASYSTOLES 8 0.0008
311 CATATONIA 4 0.0008
312 BLOOD GLUCOSE INCREASED 143 0.0008
313 NASAL DISCOMFORT 6 0.0008
314 BLOOD ALBUMIN DECREASED 6 0.0008
315 PATENT DUCTUS ARTERIOSUS 3 0.0008
316 MEDICATION ERROR 42 0.0008
317 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
318 BLOOD DISORDER 6 0.0007
319 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
320 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
321 RHABDOMYOLYSIS 31 0.0007
322 DECUBITUS ULCER 6 0.0007
323 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
324 HYPERAESTHESIA 6 0.0007
325 BLOOD GLUCOSE FLUCTUATION 8 0.0007
326 ABASIA 18 0.0007
327 CONGESTIVE CARDIOMYOPATHY 3 0.0007
328 STREPTOCOCCAL INFECTION 4 0.0007
329 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
330 GENERALISED ERYTHEMA 4 0.0007
331 METASTATIC NEOPLASM 3 0.0007
332 GRAFT VERSUS HOST DISEASE 5 0.0007
333 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
334 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
335 EMPHYSEMA 7 0.0007
336 HEPATIC LESION 3 0.0007
337 OCULAR ICTERUS 3 0.0007
338 SEDATION 18 0.0007
339 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
340 HYPERKALAEMIA 24 0.0007
341 DYSPHEMIA 3 0.0007
342 HYPERTRIGLYCERIDAEMIA 4 0.0007
343 HYPOGLYCAEMIA 33 0.0007
344 GINGIVAL SWELLING 3 0.0007
345 MEDICAL DEVICE COMPLICATION 5 0.0007
346 RHINITIS ALLERGIC 3 0.0007
347 PULMONARY HYPERTENSION 14 0.0007
348 ERUCTATION 13 0.0007
349 MUSCLE RIGIDITY 8 0.0007
350 MENINGITIS ASEPTIC 3 0.0007
351 HYDRONEPHROSIS 5 0.0007
352 HEPATITIS CHOLESTATIC 4 0.0007
353 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
354 OSTEOMYELITIS 12 0.0007
355 PLATELET COUNT ABNORMAL 4 0.0007
356 ACIDOSIS 5 0.0007
357 RESPIRATORY DISTRESS 18 0.0007
358 LOCALISED OEDEMA 3 0.0006
359 ATRIOVENTRICULAR BLOCK 5 0.0006
360 COORDINATION ABNORMAL 9 0.0006
361 CHOLANGITIS 4 0.0006
362 THINKING ABNORMAL 12 0.0006
363 SKIN LACERATION 7 0.0006
364 GASTRITIS EROSIVE 3 0.0006
365 EJECTION FRACTION DECREASED 10 0.0006
366 TREMOR 106 0.0006
367 TORSADE DE POINTES 5 0.0006
368 VOMITING 299 0.0006
369 WEIGHT DECREASED 176 0.0006
370 ATRIAL FLUTTER 5 0.0006
371 MALNUTRITION 7 0.0006
372 MYDRIASIS 8 0.0006
373 HUMERUS FRACTURE 3 0.0006
374 ALANINE AMINOTRANSFERASE INCREASED 38 0.0006
375 POOR QUALITY DRUG ADMINISTERED 4 0.0006
376 ESCHERICHIA INFECTION 5 0.0006
377 GASTROINTESTINAL DISORDER 54 0.0006
378 EMBOLISM 5 0.0006
379 COAGULOPATHY 10 0.0006
380 EOSINOPHIL COUNT INCREASED 5 0.0006
381 BLOOD POTASSIUM DECREASED 18 0.0006
382 FEAR 16 0.0006
383 KLEBSIELLA INFECTION 3 0.0006
384 METASTASES TO LYMPH NODES 4 0.0006
385 LETHARGY 34 0.0006
386 MOTOR DYSFUNCTION 6 0.0006
387 INADEQUATE ANALGESIA 5 0.0006
388 TACHYPNOEA 8 0.0006
389 CIRCULATORY COLLAPSE 10 0.0006
390 EUPHORIC MOOD 6 0.0006
391 BRADYCARDIA 31 0.0006
392 EYE MOVEMENT DISORDER 4 0.0006
393 ERECTILE DYSFUNCTION 15 0.0006
394 SCAR 10 0.0006
395 HAEMATURIA 20 0.0006
396 NEPHROTIC SYNDROME 4 0.0006
397 DROOLING 4 0.0006
398 CARDIAC MURMUR 5 0.0006
399 HYPERTENSION 122 0.0006
400 APLASTIC ANAEMIA 3 0.0006
401 CHOLESTASIS 11 0.0006
402 CYANOSIS 9 0.0006
403 SPINAL OSTEOARTHRITIS 5 0.0006
404 PULMONARY TOXICITY 4 0.0006
405 GENERALISED OEDEMA 7 0.0006
406 ILEUS 7 0.0006
407 DIVERTICULUM 4 0.0006
408 WRONG DRUG ADMINISTERED 5 0.0006
409 SUBDURAL HAEMATOMA 8 0.0006
410 INJECTION SITE DISCHARGE 3 0.0006
411 BLOOD BILIRUBIN INCREASED 15 0.0006
412 DISORIENTATION 22 0.0006
413 PRURITUS GENERALISED 12 0.0006
414 HYPERGLYCAEMIA 20 0.0005
415 GASTROENTERITIS 8 0.0005
416 RESPIRATORY ARREST 15 0.0005
417 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
418 GASTRIC ULCER HAEMORRHAGE 3 0.0005
419 DEHYDRATION 72 0.0005
420 NECROSIS 3 0.0005
421 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
422 CEREBRAL HAEMORRHAGE 19 0.0005
423 NAUSEA 420 0.0005
424 PREMATURE LABOUR 3 0.0005
425 ABNORMAL BEHAVIOUR 21 0.0005
426 MYOCARDIAL ISCHAEMIA 6 0.0005
427 GRANULOCYTOPENIA 3 0.0005
428 HAEMODYNAMIC INSTABILITY 4 0.0005
429 FEELING JITTERY 10 0.0005
430 HYPERTONIA 3 0.0005
431 SHOCK 12 0.0005
432 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
433 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
434 ATRIAL FIBRILLATION 50 0.0005
435 HYPOVOLAEMIA 3 0.0005
436 NERVOUS SYSTEM DISORDER 16 0.0005
437 COLD SWEAT 9 0.0005
438 HYPERCHLORHYDRIA 3 0.0005
439 ENERGY INCREASED 3 0.0005
440 DRUG SCREEN POSITIVE 4 0.0005
441 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
442 CATARACT OPERATION 3 0.0005
443 SINUS HEADACHE 3 0.0005
444 ASTHMA 57 0.0005
445 CARDIO-RESPIRATORY ARREST 21 0.0005
446 CONFUSIONAL STATE 81 0.0005
447 HYPOTONIA 5 0.0005
448 TRANSPLANT REJECTION 4 0.0005
449 HYPOTENSION 100 0.0005
450 GANGRENE 3 0.0005
451 CRYING 18 0.0005
452 GASTRITIS 13 0.0005
453 SUBARACHNOID HAEMORRHAGE 5 0.0005
454 BRONCHOSPASM 7 0.0005
455 BODY TEMPERATURE INCREASED 10 0.0005
456 PANCREATITIS ACUTE 11 0.0005
457 ENCEPHALOPATHY 12 0.0005
458 INITIAL INSOMNIA 5 0.0005
459 PIGMENTATION DISORDER 3 0.0005
460 MENSTRUAL DISORDER 4 0.0005
461 AGEUSIA 12 0.0005
462 MULTIPLE SCLEROSIS 23 0.0005
463 FLUID OVERLOAD 7 0.0005
464 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
465 PETECHIAE 5 0.0005
466 NASAL DRYNESS 3 0.0005
467 SCREAMING 3 0.0005
468 PULMONARY OEDEMA 21 0.0005
469 DYSKINESIA 19 0.0005
470 RESTLESSNESS 17 0.0005
471 DECREASED ACTIVITY 5 0.0005
472 HAEMATOMA 12 0.0005
473 MYOPATHY 4 0.0005
474 CARDIAC FAILURE CONGESTIVE 37 0.0005
475 LOSS OF CONSCIOUSNESS 59 0.0005
476 DEVICE FAILURE 7 0.0005
477 BRADYPHRENIA 3 0.0005
478 HAEMOGLOBIN DECREASED 47 0.0005
479 TREATMENT NONCOMPLIANCE 25 0.0005
480 PULMONARY CONGESTION 6 0.0005
481 PHARYNGEAL OEDEMA 7 0.0005
482 STAPHYLOCOCCAL INFECTION 15 0.0005
483 IMMUNOSUPPRESSION 4 0.0005
484 LYMPHADENOPATHY 16 0.0005
485 CEREBRAL INFARCTION 11 0.0004
486 INFLUENZA LIKE ILLNESS 37 0.0004
487 JAUNDICE 12 0.0004
488 MYOSITIS 4 0.0004
489 COLITIS ISCHAEMIC 3 0.0004
490 STATUS EPILEPTICUS 5 0.0004
491 HYPERHIDROSIS 57 0.0004
492 ASTHENIA 166 0.0004
493 COMA 21 0.0004
494 FLATULENCE 25 0.0004
495 GINGIVAL BLEEDING 6 0.0004
496 OBESITY 7 0.0004
497 CROHN'S DISEASE 3 0.0004
498 SENSORY DISTURBANCE 7 0.0004
499 PANCREATITIS 23 0.0004
500 HYPOKALAEMIA 20 0.0004
501 AUTOIMMUNE HEPATITIS 3 0.0004
502 BLOOD POTASSIUM INCREASED 7 0.0004
503 HUNGER 6 0.0004
504 PERSONALITY CHANGE 4 0.0004
505 HEPATITIS 11 0.0004
506 POST PROCEDURAL HAEMORRHAGE 5 0.0004
507 ERYTHEMA MULTIFORME 4 0.0004
508 TACHYCARDIA 38 0.0004
509 CHILLS 50 0.0004
510 OSTEONECROSIS 14 0.0004
511 ARTERIOSCLEROSIS 4 0.0004
512 RASH GENERALISED 11 0.0004
513 BLOOD SODIUM DECREASED 8 0.0004
514 HEART RATE INCREASED 42 0.0004
515 DIPLOPIA 11 0.0004
516 PLATELET COUNT DECREASED 45 0.0004
517 RETCHING 9 0.0004
518 FEBRILE NEUTROPENIA 28 0.0004
519 BACTERAEMIA 5 0.0004
520 RETINAL HAEMORRHAGE 3 0.0004
521 NERVOUSNESS 22 0.0004
522 IMPAIRED WORK ABILITY 9 0.0004
523 NEUTROPENIC SEPSIS 3 0.0004
524 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
525 PANIC REACTION 3 0.0004
526 DERMATITIS BULLOUS 3 0.0004
527 HYPERTHYROIDISM 6 0.0004
528 ANGER 14 0.0004
529 TINNITUS 19 0.0004
530 HEMIPARESIS 7 0.0004
531 DIZZINESS POSTURAL 4 0.0004
532 BURSITIS 5 0.0004
533 RASH PUSTULAR 3 0.0004
534 CARDIAC ARREST 34 0.0004
535 HEAD INJURY 13 0.0004
536 MAJOR DEPRESSION 3 0.0004
537 ORAL DISORDER 3 0.0004
538 MOUTH HAEMORRHAGE 3 0.0004
539 MELAENA 9 0.0004
540 AGITATION 30 0.0004
541 CYSTITIS 13 0.0004
542 RESPIRATORY DEPRESSION 5 0.0004
543 DISTURBANCE IN ATTENTION 22 0.0004
544 RENAL DISORDER 19 0.0004
545 PARANOIA 7 0.0004
546 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
547 URINARY INCONTINENCE 12 0.0004
548 DYSPNOEA 228 0.0004
549 ORTHOSTATIC HYPOTENSION 7 0.0004
550 HEPATIC FUNCTION ABNORMAL 15 0.0004
551 RESPIRATORY DISORDER 12 0.0004
552 PYREXIA 138 0.0004
553 HEART RATE IRREGULAR 9 0.0004
554 METASTASES TO LIVER 7 0.0004
555 HEPATIC FAILURE 12 0.0004
556 HYPOAESTHESIA ORAL 6 0.0004
557 TOXIC SKIN ERUPTION 4 0.0004
558 BRAIN OEDEMA 5 0.0004
559 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
560 HYPOTHERMIA 4 0.0004
561 CHEST PAIN 73 0.0004
562 PANCYTOPENIA 22 0.0004
563 SUICIDAL IDEATION 36 0.0004
564 DRUG DISPENSING ERROR 6 0.0004
565 VISUAL ACUITY REDUCED 13 0.0004
566 PROCEDURAL COMPLICATION 3 0.0004
567 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
568 URINARY RETENTION 13 0.0004
569 RIB FRACTURE 8 0.0004
570 HAEMOLYSIS 3 0.0004
571 LYMPHOMA 6 0.0004
572 TENDONITIS 6 0.0004
573 CONCUSSION 3 0.0004
574 SKIN ULCER 10 0.0004
575 LEUKOCYTOSIS 7 0.0004
576 LUNG INFECTION 6 0.0004
577 HYPOALBUMINAEMIA 3 0.0004
578 PELVIC FRACTURE 3 0.0004
579 ANGINA PECTORIS 11 0.0004
580 PULMONARY HAEMORRHAGE 3 0.0004
581 PNEUMONIA 124 0.0004
582 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
583 MUCOSAL INFLAMMATION 10 0.0004
584 ANAPHYLACTIC REACTION 21 0.0004
585 LEUKOPENIA 19 0.0004
586 SYNCOPE 38 0.0004
587 AGGRESSION 19 0.0004
588 IMMUNE SYSTEM DISORDER 5 0.0004
589 RENAL CYST 3 0.0004
590 OSTEOARTHRITIS 16 0.0004
591 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
592 RECTAL HAEMORRHAGE 16 0.0004
593 LOCALISED INFECTION 9 0.0004
594 DYSPNOEA EXERTIONAL 14 0.0004
595 MENTAL IMPAIRMENT 9 0.0004
596 WHEEZING 22 0.0004
597 FOOT FRACTURE 7 0.0004
598 FAECES DISCOLOURED 8 0.0004
599 BIPOLAR DISORDER 4 0.0004
600 PALLOR 10 0.0004
601 AKATHISIA 5 0.0004
602 POLYURIA 3 0.0004
603 INCREASED APPETITE 7 0.0004
604 ABNORMAL FAECES 3 0.0004
605 IRRITABILITY 22 0.0004
606 MANIA 6 0.0004
607 DRUG WITHDRAWAL SYNDROME 32 0.0004
608 CORONARY ARTERY OCCLUSION 5 0.0004
609 SEROTONIN SYNDROME 7 0.0004
610 GASTROINTESTINAL PAIN 4 0.0004
611 PRESCRIBED OVERDOSE 7 0.0004
612 DENTAL CARIES 4 0.0004
613 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
614 CYTOMEGALOVIRUS INFECTION 6 0.0004
615 HEMIPLEGIA 3 0.0004
616 FEELING COLD 10 0.0004
617 HYPOMAGNESAEMIA 5 0.0004
618 HAEMORRHOIDS 7 0.0004
619 EMOTIONAL DISORDER 11 0.0004
620 NEPHROPATHY TOXIC 4 0.0004
621 BLOOD CALCIUM DECREASED 4 0.0004
622 HAEMATEMESIS 9 0.0004
623 BLINDNESS UNILATERAL 5 0.0004
624 RENAL FAILURE 47 0.0004
625 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
626 SWOLLEN TONGUE 11 0.0004
627 MULTIPLE SCLEROSIS RELAPSE 24 0.0003
628 DYSGEUSIA 26 0.0003
629 UNRESPONSIVE TO STIMULI 9 0.0003
630 GASTRIC HAEMORRHAGE 4 0.0003
631 DISEASE PROGRESSION 41 0.0003
632 BLOOD PRESSURE DECREASED 23 0.0003
633 DYSPEPSIA 34 0.0003
634 MOOD SWINGS 11 0.0003
635 DYSSTASIA 10 0.0003
636 GROIN PAIN 3 0.0003
637 SPLENOMEGALY 4 0.0003
638 NECK PAIN 19 0.0003
639 ACUTE MYOCARDIAL INFARCTION 10 0.0003
640 PSYCHOTIC DISORDER 10 0.0003
641 DEEP VEIN THROMBOSIS 22 0.0003
642 ATAXIA 4 0.0003
643 CARDIAC FAILURE 27 0.0003
644 THIRST 6 0.0003
645 CHOLELITHIASIS 11 0.0003
646 IMPAIRED HEALING 11 0.0003
647 VISION BLURRED 46 0.0003
648 HAEMORRHAGE INTRACRANIAL 5 0.0003
649 DEPRESSION 76 0.0003
650 LOSS OF LIBIDO 3 0.0003
651 OEDEMA 18 0.0003
652 HALLUCINATION, VISUAL 7 0.0003
653 DECREASED APPETITE 77 0.0003
654 LUPUS-LIKE SYNDROME 3 0.0003
655 PELVIC PAIN 6 0.0003
656 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
657 IRRITABLE BOWEL SYNDROME 7 0.0003
658 DRUG ADMINISTRATION ERROR 10 0.0003
659 OVARIAN CANCER 3 0.0003
660 DIZZINESS 162 0.0003
661 ANKLE FRACTURE 5 0.0003
662 AGRANULOCYTOSIS 6 0.0003
663 THROMBOCYTOPENIA 36 0.0003
664 FLANK PAIN 3 0.0003
665 NEUTROPHIL COUNT DECREASED 13 0.0003
666 SQUAMOUS CELL CARCINOMA 3 0.0003
667 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
668 ARRHYTHMIA 15 0.0003
669 MUSCLE ATROPHY 4 0.0003
670 GASTRIC ULCER 6 0.0003
671 PROTEINURIA 6 0.0003
672 RESPIRATORY FAILURE 23 0.0003
673 PNEUMOTHORAX 5 0.0003
674 RASH MACULO-PAPULAR 7 0.0003
675 INJECTION SITE IRRITATION 4 0.0003
676 HYPOAESTHESIA 47 0.0003
677 HYPOPHAGIA 8 0.0003
678 PRODUCT USE IN UNAPPROVED INDICATION 77 0.0003
679 CHROMATURIA 7 0.0003
680 NODULE 4 0.0003
681 KIDNEY INFECTION 6 0.0003
682 HEPATOMEGALY 3 0.0003
683 BEDRIDDEN 4 0.0003
684 MUSCLE TWITCHING 7 0.0003
685 OXYGEN SATURATION DECREASED 17 0.0003
686 BLADDER DISORDER 3 0.0003
687 DRUG LEVEL INCREASED 5 0.0003
688 PANIC ATTACK 11 0.0003
689 ABDOMINAL PAIN UPPER 62 0.0003
690 VIRAL INFECTION 10 0.0003
691 SALIVARY HYPERSECRETION 3 0.0003
692 EYE HAEMORRHAGE 4 0.0003
693 BRAIN INJURY 3 0.0003
694 PALPITATIONS 35 0.0003
695 SEPTIC SHOCK 13 0.0003
696 JOINT RANGE OF MOTION DECREASED 4 0.0003
697 APHASIA 9 0.0003
698 FEELING ABNORMAL 71 0.0003
699 VERTIGO 18 0.0003
700 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
701 DRY THROAT 3 0.0003
702 DISEASE RECURRENCE 14 0.0003
703 INSOMNIA 78 0.0003
704 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
705 HALLUCINATION 22 0.0003
706 PERIPHERAL COLDNESS 4 0.0003
707 DRUG INTERACTION 46 0.0003
708 BALANCE DISORDER 25 0.0003
709 THERAPY NON-RESPONDER 13 0.0003
710 BLOOD PRESSURE INCREASED 44 0.0003
711 LOCAL SWELLING 5 0.0003
712 SPEECH DISORDER 15 0.0003
713 FOLLICULITIS 3 0.0003
714 KNEE ARTHROPLASTY 6 0.0003
715 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
716 HYPOTHYROIDISM 9 0.0003
717 EATING DISORDER 6 0.0003
718 GALLBLADDER DISORDER 5 0.0003
719 RED BLOOD CELL COUNT DECREASED 8 0.0003
720 PARALYSIS 4 0.0003
721 FALL 93 0.0003
722 HYPERSOMNIA 8 0.0003
723 LACTIC ACIDOSIS 9 0.0003
724 CELLULITIS 14 0.0003
725 PHARYNGITIS STREPTOCOCCAL 3 0.0003
726 MYELODYSPLASTIC SYNDROME 4 0.0003
727 RESTLESS LEGS SYNDROME 5 0.0003
728 C-REACTIVE PROTEIN INCREASED 10 0.0003
729 OESOPHAGITIS 3 0.0003
730 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
731 APATHY 4 0.0003
732 ACCIDENTAL OVERDOSE 10 0.0003
733 DYSURIA 10 0.0003
734 ANAPHYLACTIC SHOCK 7 0.0003
735 MYALGIA 46 0.0003
736 BLINDNESS 11 0.0003
737 STEVENS-JOHNSON SYNDROME 6 0.0003
738 HYPERTENSIVE CRISIS 3 0.0003
739 HEPATIC STEATOSIS 5 0.0003
740 HEADACHE 168 0.0003
741 MIDDLE INSOMNIA 5 0.0003
742 HEPATIC CIRRHOSIS 5 0.0003
743 DYSARTHRIA 10 0.0003
744 UNEVALUABLE EVENT 20 0.0003
745 IMPAIRED DRIVING ABILITY 3 0.0003
746 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
747 INJECTION SITE BRUISING 21 0.0003
748 SCAB 3 0.0003
749 SKIN DISCOLOURATION 12 0.0003
750 ADVERSE EVENT 24 0.0003
751 LOWER LIMB FRACTURE 5 0.0003
752 NIGHTMARE 9 0.0003
753 ANXIETY 74 0.0003
754 FREQUENT BOWEL MOVEMENTS 7 0.0003
755 EYELID OEDEMA 3 0.0003
756 DYSTONIA 5 0.0003
757 DELUSION 4 0.0003
758 EAR PAIN 5 0.0003
759 BURNING SENSATION 18 0.0003
760 ACUTE MYELOID LEUKAEMIA 4 0.0003
761 BASAL CELL CARCINOMA 4 0.0003
762 HEART RATE DECREASED 9 0.0003
763 SEXUAL DYSFUNCTION 3 0.0003
764 ARTHRITIS 20 0.0003
765 HAEMATOCHEZIA 14 0.0003
766 ABNORMAL DREAMS 7 0.0003
767 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
768 URINARY TRACT INFECTION 43 0.0003
769 CHOLECYSTITIS 3 0.0003
770 MYOCLONUS 3 0.0003
771 MACULAR DEGENERATION 3 0.0003
772 INJECTION SITE HAEMORRHAGE 20 0.0003
773 SPINAL FRACTURE 5 0.0002
774 HEPATIC ENZYME INCREASED 17 0.0002
775 NOCTURIA 3 0.0002
776 SCHIZOPHRENIA 3 0.0002
777 AMNESIA 16 0.0002
778 LIVER INJURY 6 0.0002
779 PAIN IN EXTREMITY 72 0.0002
780 MUSCLE SPASTICITY 3 0.0002
781 BRONCHITIS 18 0.0002
782 PRODUCT SUBSTITUTION ISSUE 14 0.0002
783 INJECTION SITE EXTRAVASATION 3 0.0002
784 HYPERCALCAEMIA 3 0.0002
785 NEUTROPENIA 33 0.0002
786 PARAESTHESIA 38 0.0002
787 MYOCARDIAL INFARCTION 42 0.0002
788 INJECTION SITE DISCOLOURATION 3 0.0002
789 FUNGAL INFECTION 8 0.0002
790 COMPLETED SUICIDE 20 0.0002
791 RASH PRURITIC 13 0.0002
792 SECRETION DISCHARGE 3 0.0002
793 ROAD TRAFFIC ACCIDENT 10 0.0002
794 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
795 FATIGUE 185 0.0002
796 ABDOMINAL PAIN LOWER 6 0.0002
797 PAIN 145 0.0002
798 ROTATOR CUFF SYNDROME 3 0.0002
799 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
800 DYSPHAGIA 22 0.0002
801 DELIRIUM 8 0.0002
802 PLATELET COUNT INCREASED 3 0.0002
803 RASH ERYTHEMATOUS 11 0.0002
804 MENTAL DISORDER 10 0.0002
805 HAEMORRHAGE 24 0.0002
806 EPILEPSY 7 0.0002
807 CONTUSION 22 0.0002
808 INJECTION SITE RASH 7 0.0002
809 AMENORRHOEA 4 0.0002
810 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
811 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
812 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
813 HEPATOTOXICITY 5 0.0002
814 BACK PAIN 52 0.0002
815 MUSCLE SPASMS 41 0.0002
816 SINUS CONGESTION 3 0.0002
817 BONE PAIN 13 0.0002
818 THROAT TIGHTNESS 6 0.0002
819 GASTROENTERITIS VIRAL 4 0.0002
820 PNEUMONITIS 6 0.0002
821 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
822 SKIN LESION 6 0.0002
823 APPLICATION SITE RASH 3 0.0002
824 NEPHROLITHIASIS 10 0.0002
825 PERICARDIAL EFFUSION 5 0.0002
826 POLLAKIURIA 9 0.0002
827 APHONIA 3 0.0002
828 ILL-DEFINED DISORDER 13 0.0002
829 EPISTAXIS 16 0.0002
830 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
831 SKIN REACTION 3 0.0002
832 INFUSION RELATED REACTION 14 0.0002
833 MUSCULAR WEAKNESS 24 0.0002
834 MUSCULOSKELETAL PAIN 11 0.0002
835 GAIT DISTURBANCE 40 0.0002
836 DRUG PRESCRIBING ERROR 4 0.0002
837 ACUTE RESPIRATORY FAILURE 4 0.0002
838 CEREBROVASCULAR ACCIDENT 35 0.0002
839 INTERSTITIAL LUNG DISEASE 10 0.0002
840 FIBROMYALGIA 5 0.0002
841 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
842 CHEST DISCOMFORT 21 0.0002
843 MALIGNANT NEOPLASM PROGRESSION 21 0.0002
844 DIARRHOEA 132 0.0002
845 MENORRHAGIA 4 0.0002
846 URTICARIA 34 0.0002
847 SINUS DISORDER 4 0.0002
848 BLOOD PRESSURE ABNORMAL 4 0.0002
849 UPPER LIMB FRACTURE 4 0.0002
850 THROAT IRRITATION 9 0.0002
851 ABORTION SPONTANEOUS 8 0.0002
852 LACRIMATION INCREASED 6 0.0002
853 PRODUCT ADMINISTRATION ERROR 4 0.0002
854 BONE MARROW FAILURE 4 0.0002
855 HIP ARTHROPLASTY 3 0.0002
856 LUNG NEOPLASM MALIGNANT 8 0.0002
857 INFLAMMATION 10 0.0002
858 INFECTION 28 0.0002
859 PERITONITIS 4 0.0002
860 APPLICATION SITE ERYTHEMA 5 0.0002
861 PRODUCTIVE COUGH 9 0.0002
862 SCIATICA 3 0.0002
863 ABSCESS 3 0.0002
864 METABOLIC ACIDOSIS 6 0.0002
865 HYPOACUSIS 8 0.0002
866 POOR QUALITY SLEEP 4 0.0002
867 BACK DISORDER 3 0.0002
868 SWELLING FACE 12 0.0002
869 WEIGHT INCREASED 41 0.0002
870 METASTASES TO BONE 3 0.0002
871 ARTHROPATHY 10 0.0002
872 INFLUENZA 20 0.0002
873 PERICARDITIS 3 0.0002
874 SNEEZING 4 0.0002
875 FACE OEDEMA 3 0.0002
876 TARDIVE DYSKINESIA 5 0.0002
877 RASH 75 0.0002
878 BREAST CANCER 16 0.0002
879 RASH MACULAR 6 0.0002
880 DRUG INEFFECTIVE 225 0.0002
881 LABORATORY TEST ABNORMAL 5 0.0002
882 PRODUCT QUALITY ISSUE 23 0.0002
883 DRUG ERUPTION 3 0.0002
884 OFF LABEL USE 148 0.0002
885 OCULAR HYPERAEMIA 8 0.0002
886 COUGH 47 0.0002
887 OVERDOSE 36 0.0002
888 RENAL IMPAIRMENT 14 0.0002
889 SKIN EXFOLIATION 14 0.0002
890 STOMATITIS 10 0.0002
891 PRESYNCOPE 4 0.0002
892 EYE SWELLING 6 0.0002
893 ARTHRALGIA 67 0.0002
894 BLISTER 9 0.0002
895 MEMORY IMPAIRMENT 22 0.0002
896 PNEUMONIA ASPIRATION 4 0.0002
897 PHOTOPHOBIA 3 0.0002
898 INTESTINAL OBSTRUCTION 6 0.0002
899 BLOOD URINE PRESENT 3 0.0002
900 MUSCULOSKELETAL DISORDER 3 0.0002
901 JOINT SWELLING 19 0.0002
902 MALAISE 69 0.0002
903 SLEEP APNOEA SYNDROME 3 0.0002
904 INJURY 11 0.0002
905 SINUSITIS 16 0.0002
906 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
907 HIP FRACTURE 5 0.0002
908 NIGHT SWEATS 5 0.0002
909 RHINORRHOEA 10 0.0002
910 DYSPHONIA 9 0.0002
911 RESPIRATORY TRACT INFECTION 4 0.0002
912 DEAFNESS 4 0.0002
913 ANHEDONIA 4 0.0002
914 EYE DISORDER 5 0.0002
915 CATARACT 9 0.0002
916 HYPERSENSITIVITY 28 0.0002
917 EAR INFECTION 4 0.0002
918 COGNITIVE DISORDER 7 0.0001
919 CARDIAC DISORDER 14 0.0001
920 MENSTRUATION IRREGULAR 4 0.0001
921 THERAPEUTIC RESPONSE DECREASED 9 0.0001
922 DISCOMFORT 9 0.0001
923 LIMB INJURY 4 0.0001
924 PRODUCT DOSE OMISSION ISSUE 43 0.0001
925 HOT FLUSH 11 0.0001
926 OSTEOPOROSIS 6 0.0001
927 GASTRIC DISORDER 5 0.0001
928 WOUND 4 0.0001
929 SKIN CANCER 3 0.0001
930 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
931 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
932 FLUID RETENTION 7 0.0001
933 NEUROPATHY PERIPHERAL 13 0.0001
934 APPLICATION SITE PAIN 3 0.0001
935 NASAL CONGESTION 8 0.0001
936 ANGIOEDEMA 6 0.0001
937 GLOSSODYNIA 3 0.0001
938 ORAL PAIN 3 0.0001
939 APPLICATION SITE PRURITUS 3 0.0001
940 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
941 MOBILITY DECREASED 9 0.0001
942 PRURITUS 48 0.0001
943 NASOPHARYNGITIS 23 0.0001
944 MOVEMENT DISORDER 4 0.0001
945 INJECTION SITE ERYTHEMA 15 0.0001
946 LIP SWELLING 4 0.0001
947 SKIN DISORDER 4 0.0001
948 FLUSHING 12 0.0001
949 ERYTHEMA 24 0.0001
950 INJECTION SITE REACTION 8 0.0001
951 MIGRAINE 11 0.0001
952 VAGINAL HAEMORRHAGE 5 0.0001
953 JOINT STIFFNESS 3 0.0001
954 DEPRESSED MOOD 6 0.0001
955 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
956 MOOD ALTERED 3 0.0001
957 INTENTIONAL OVERDOSE 7 0.0001
958 PROCEDURAL PAIN 3 0.0001
959 COLITIS 4 0.0001
960 INJECTION SITE PRURITUS 7 0.0001
961 INJECTION SITE SWELLING 8 0.0001
962 DRY EYE 5 0.0001
963 SUICIDE ATTEMPT 6 0.0001
964 DEATH 85 0.0001
965 PSORIATIC ARTHROPATHY 4 0.0001
966 OROPHARYNGEAL PAIN 9 0.0001
967 INCORRECT DOSE ADMINISTERED 21 0.0001
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
969 DRY SKIN 12 0.0001
970 VISUAL IMPAIRMENT 11 0.0001
971 INJECTION SITE PAIN 25 0.0001
972 ALOPECIA 14 0.0001
973 EYE PAIN 4 0.0001
974 HERPES ZOSTER 4 0.0001
975 EYE IRRITATION 4 0.0001
976 PSORIASIS 9 0.0001
977 COLITIS ULCERATIVE 3 0.0001
978 ABDOMINAL DISCOMFORT 11 0.0001
979 SKIN IRRITATION 3 0.0001
980 DRUG DEPENDENCE 10 0.0001
981 TREATMENT FAILURE 5 0.0001
982 NEOPLASM MALIGNANT 4 0.0001
983 EMOTIONAL DISTRESS 7 0.0001
984 ADVERSE DRUG REACTION 5 0.0001
985 RHEUMATOID ARTHRITIS 6 0.0001
986 BLADDER CANCER 3 0.0001
987 FEELING HOT 3 0.0000
988 DRUG ABUSE 4 0.0000
989 DEVICE MALFUNCTION 3 0.0000
990 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
991 ACNE 3 0.0000
992 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
993 DRUG DOSE OMISSION 4 0.0000
994 PERIPHERAL SWELLING 3 0.0000